Could a la carte pricing be a consideration in improving revenue for radiologists in private practice?
|Articles|November 29, 2007
Wide-bore PET/CT debuts at Philips both
Philips Medical Systems is showing this week its next-generation large-bore PET/CT at the RSNA meeting. The new hybrid, appearing as a work-in-progress, combines the Gemini TF (True Flight) PET/CT with time-of-flight technology and the Brilliance wide-bore CT. The PET/CT features an 85-cm diameter for both PET and CT. Included are simulation protocols, respiratory gating, and connectivity for data transfer in radiation oncology.
Advertisement
Philips Medical Systems is showing this week its next-generation large-bore PET/CT at the RSNA meeting. The new hybrid, appearing as a work-in-progress, combines the Gemini TF (True Flight) PET/CT with time-of-flight technology and the Brilliance wide-bore CT. The PET/CT features an 85-cm diameter for both PET and CT. Included are simulation protocols, respiratory gating, and connectivity for data transfer in radiation oncology.
Advertisement
Related to this article
Catch up on a variety of FDA news in radiology from the past week.
Catch up on the top radiology content of the past week.
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Incorporating structural MRI to improve PET imaging resolution, the MICSI-PET software also offers automated Centiloid quantification from amyloid PET scans.
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
For patients with intermediate-risk prostate cancer, those with lower apparent diffusion coefficient (ADC) values on pre-treatment DWI MRI had a fourfold higher prevalence of distant metastasis in a study with a 10.3-year median follow-up.
In the second of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss challenges with evaluating value and ROI for AI software, the physician time required to do so, and possible solutions to facilitate improved clarity and consistency with AI reimbursement.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Radiology Roundup of FDA News: September 13 — September 19
2
FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET
3
Does kV Still Matter in Photon-Counting CT?
4
Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod
5